AF	atrial fibrillation
ASA	acetylsalicylic acid
AT	antithrombotic therapy
BEV	balloon-expandable valve
CT	computed tomography
DAT	dual antithrombotic therapy
DAPT	dual antiplatelet therapy
DOAC	direct oral anticoagulant
DRT	device-related thrombosis
FU	follow-up
GI	gastrointestinal
HALT	hypoattenuated leaflet thickening
INR	international normalized ratio
LAAO	left atrial appendage occlusion
LD	low dose
LOE	level of evidence
NACE	net adverse clinical events
OAC	oral anticoagulation
PAD	peripheral artery disease
PCI	percutaneous coronary intervention
PFO	patent foramen ovale
RCT	randomized controlled trial
RLM	restricted leaflet motion
SAPT	single antiplatelet therapy
SEV	self-expanding valve
SLT	subclinical leaflet thrombosis
TAVI	transcatheter aortic valve implantation
TEER	mitral transcatheter edge-to-edge repair
TIA	transient ischemic attack
TMVR	transcatheter mitral valve replacement
TR	tricuspid regurgitation
TTVR	transcatheter tricuspid valve replacement
UFH	unfractionated heparin
VKA	vitamin K antagonist